Apremilast 30mg tablets
NHS hospitals in England used £16,155,996 of indicative cost of Apremilast 30mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 2.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Apremilast 30mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Apremilast 30mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Hull And East Yorkshire Hpls Nhs Trust | £1,015,025 |
| Gloucestershire Hpls Nhs Foundation Trst | £948,210 |
| St Helens & Knowsley Hospitals Nhs Trust | £666,001 |
| East Kent Hospitals University Nhs Ft | £600,050 |
| Portsmouth Hospitals Nhs Trust | £583,354 |
| Leeds Teaching Hpls Nhs Trust | £550,550 |
| Aintree University Hospital Nhs Ft | £544,500 |
| Co.durham & Darlington Nhs Foundation Tr | £540,925 |
| Bradford Teaching Hospitals Nhs Ft | £540,493 |
| United Lincolnshire Hospitals Nhs Trust | £349,751 |
The primary-care picture
Apremilast is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Apremilast medicine page.